Scarless wound healing: Current insights from the perspectives of TGF-β, KGF-1, and KGF-2

Wang Xiaojie1, Joshua Banda1, Hui Qi1

  • 1Wenzhou Medical University, China.

Insights

Transforming growth factor-β (TGF-β) inhibition and keratinocyte growth factors (KGF), KGF-1 and KGF-2, show promise in accelerating wound healing and reducing scarring. Further research is needed to fully understand their roles and optimize their use in wound management.

Area of Science:

  • Regenerative Medicine
  • Dermatology
  • Biochemistry

Background:

  • Wound healing is a complex biological process involving inflammation, proliferation, and remodeling.
  • Dysregulation of wound healing can lead to scarring or chronic non-healing wounds.
  • Early wound healing events significantly influence the final outcome, with high inflammation linked to scarring.

Purpose of the Study:

  • To review current knowledge on the roles of TGF-β, KGF1, and KGF2 in wound healing and scar formation.
  • To identify areas requiring further investigation in growth factor-mediated wound repair.
  • To discuss future therapeutic strategies utilizing growth factors for improved wound management.

Main Methods:

  • Literature review of recent studies on growth factors in wound healing.
  • Analysis of the molecular mechanisms of TGF-β, KGF1, and KGF2.
  • Synthesis of findings regarding therapeutic interventions and future research directions.

Main Results:

  • Inhibition of TGF-β and administration of KGFs (KGF-1, KGF-2) have demonstrated accelerated wound closure and reduced scarring.
  • These growth factors play critical roles in coordinating cellular interactions during healing.
  • Understanding their precise regulation is key to achieving scarless healing.

Conclusions:

  • Targeting TGF-β and utilizing KGFs represent promising strategies for enhancing wound healing and minimizing scar formation.
  • Further research is essential to elucidate the complete mechanisms and optimize clinical applications of these growth factors.
  • Future directions include exploring novel combinations and delivery methods for advanced wound care.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
Phases of Wound Repair01:28

Phases of Wound Repair

Following injury, the integrity of the injured tissues must be reestablished. For example, in skin tissue, wound repair involves coordination among resident skin cells, blood mononuclear cells, extracellular matrix, growth factors, and cytokines to complete the healing cascade.
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
6.5K
Overview of Regeneration and Repair01:19

Overview of Regeneration and Repair

Regeneration and repair processes are critical in healing damages caused by injury, disease, and aging. In regeneration, the damaged tissue is entirely replaced with new growth that restores the original architecture and function. In contrast, tissue repair usually results in a fixed tissue architecture involving scar formation. Scars generally do not reestablish tissue function and may also exhibit structural abnormalities at the injury site.
Regeneration
All animals have varying degrees of...
4.3K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.8K